XML 56 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Sep. 27, 2014
Sep. 28, 2013
Sep. 29, 2012
OPERATING ACTIVITIES:      
Net income $ 2,590,767us-gaap_NetIncomeLoss $ 5,067,417us-gaap_NetIncomeLoss $ 5,214,973us-gaap_NetIncomeLoss
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 864,356us-gaap_Depreciation 775,767us-gaap_Depreciation 756,656us-gaap_Depreciation
Amortization 424,169us-gaap_AdjustmentForAmortization 509,247us-gaap_AdjustmentForAmortization 452,670us-gaap_AdjustmentForAmortization
Provision for losses on accounts receivable 128,925us-gaap_ProvisionForDoubtfulAccounts 91,623us-gaap_ProvisionForDoubtfulAccounts 32,008us-gaap_ProvisionForDoubtfulAccounts
Provision (Benefit) for deferred income taxes 50,703us-gaap_DeferredIncomeTaxExpenseBenefit 166,000us-gaap_DeferredIncomeTaxExpenseBenefit (66,000)us-gaap_DeferredIncomeTaxExpenseBenefit
Gain on sale and disposal of property and equipment (73)us-gaap_GainLossOnSaleOfPropertyPlantEquipment (916)us-gaap_GainLossOnSaleOfPropertyPlantEquipment  
Increase in cash value of life insurance (174,943)us-gaap_IncreaseDecreaseInLifeInsuranceLiabilities (184,786)us-gaap_IncreaseDecreaseInLifeInsuranceLiabilities (194,806)us-gaap_IncreaseDecreaseInLifeInsuranceLiabilities
Deferred compensation (76,783)us-gaap_IncreaseDecreaseInDeferredCompensation (20,048)us-gaap_IncreaseDecreaseInDeferredCompensation (54,705)us-gaap_IncreaseDecreaseInDeferredCompensation
Stock compensation expense 26,637us-gaap_ShareBasedCompensation 34,242us-gaap_ShareBasedCompensation 72,264us-gaap_ShareBasedCompensation
Changes in operating assets and liabilities:      
Accounts receivable 1,692,566us-gaap_IncreaseDecreaseInReceivables 295,550us-gaap_IncreaseDecreaseInReceivables (69,307)us-gaap_IncreaseDecreaseInReceivables
Inventories (1,106,616)us-gaap_IncreaseDecreaseInInventories 2,898,492us-gaap_IncreaseDecreaseInInventories 520,981us-gaap_IncreaseDecreaseInInventories
Prepaid expenses and other assets 164,708us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (296,204)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets 256,544us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Accounts payable and accrued and sundry liabilities (927,407)us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities (1,117,533)us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities (55,964)us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
Net cash provided by operating activities 3,657,009us-gaap_NetCashProvidedByUsedInOperatingActivities 8,218,851us-gaap_NetCashProvidedByUsedInOperatingActivities 6,865,314us-gaap_NetCashProvidedByUsedInOperatingActivities
INVESTING ACTIVITIES:      
Acquisition of M.C. Healthcare     (8,251,831)us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Proceeds from sale of securities available for sale     4,000,000us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities
Purchases of property and equipment (670,845)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (557,863)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (684,327)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Proceeds from sale of property and equipment 914us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment 7,850us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment  
Payments for other assets (80,593)us-gaap_PaymentsForProceedsFromOtherInvestingActivities (110,586)us-gaap_PaymentsForProceedsFromOtherInvestingActivities (107,528)us-gaap_PaymentsForProceedsFromOtherInvestingActivities
Net cash used for investing activities (750,524)us-gaap_NetCashProvidedByUsedInInvestingActivities (660,599)us-gaap_NetCashProvidedByUsedInInvestingActivities (5,043,686)us-gaap_NetCashProvidedByUsedInInvestingActivities
FINANCING ACTIVITIES:      
Dividends paid (1,683,011)us-gaap_PaymentsOfDividends (4,439,382)us-gaap_PaymentsOfDividends (1,358,425)us-gaap_PaymentsOfDividends
Proceeds from long-term debt     9,300,000us-gaap_ProceedsFromIssuanceOfLongTermDebt
Repayment of long-term debt     (9,300,000)us-gaap_RepaymentsOfLongTermDebt
Purchase and retirement of common stock   (450,000)us-gaap_PaymentsForRepurchaseOfCommonStock  
Proceeds from exercise of options for common stock 273,397us-gaap_ProceedsFromStockOptionsExercised 152,647us-gaap_ProceedsFromStockOptionsExercised 68,946us-gaap_ProceedsFromStockOptionsExercised
Net cash used for financing activities (1,409,614)us-gaap_NetCashProvidedByUsedInFinancingActivities (4,736,735)us-gaap_NetCashProvidedByUsedInFinancingActivities (1,289,479)us-gaap_NetCashProvidedByUsedInFinancingActivities
Effect of exchange rates on cash (55,461)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents (62,298)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents 8,747us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents
Increase in cash and cash equivalents 1,441,410us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 2,759,219us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 540,896us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents at beginning of year 5,424,521us-gaap_CashAndCashEquivalentsAtCarryingValue 2,665,302us-gaap_CashAndCashEquivalentsAtCarryingValue 2,124,406us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents at end of year $ 6,865,931us-gaap_CashAndCashEquivalentsAtCarryingValue $ 5,424,521us-gaap_CashAndCashEquivalentsAtCarryingValue $ 2,665,302us-gaap_CashAndCashEquivalentsAtCarryingValue